SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+8.99%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$765M
AUM Growth
+$765M
(+22%)
Cap. Flow
+$104M
Cap. Flow
% of AUM
13.54%
Top 10 Holdings %
Top 10 Hldgs %
42.01%
Holding
140
New
30
Increased
44
Reduced
18
Closed
26
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
$44.9M |
| 2 |
Bristol-Myers Squibb
BMY
|
$33.5M |
| 3 |
Viatris
VTRS
|
$17.2M |
| 4 |
argenx
ARGX
|
$10.3M |
| 5 |
PTC Therapeutics
PTCT
|
$9.87M |
Top Sells
| 1 |
SHPG
Shire pic
SHPG
|
$21.4M |
| 2 |
Amgen
AMGN
|
$18.5M |
| 3 |
Biogen
BIIB
|
$14.5M |
| 4 |
Pfizer
PFE
|
$14.1M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$13.6M |
Sector Composition
| 1 | Healthcare | 85.91% |
| 2 | Technology | 5.46% |
| 3 | Industrials | 2.69% |
| 4 | Financials | 1.45% |
| 5 | Materials | 0.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Scholar Rock
SRRK
$3.14B
| $7.64M | 0.88% | 296,856 +12,859 | +5% | +$331K |
|
|
RETA
27
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $7.58M | 0.87% | 92,719 -43,325 | -32% | -$3.54M |
|
28
Verint Systems
VRNT
$1.23B
| $7.52M | 0.86% | +150,126 | New | +$7.52M |
|
29
Clearside Biomedical
CLSD
$28.9M
| $7.1M | 0.82% | 1,154,690 +85,970 | +8% | +$529K |
|
30
Ascendis Pharma
ASND
$11.8B
| $6.57M | 0.75% | 92,673 +14,625 | +19% | +$1.04M |
|
31
uniQure
QURE
$896M
| $6.47M | 0.74% | 177,849 +25,359 | +17% | +$923K |
|
|
MLNT
32
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
| $6.39M | 0.73% | 1,616,867 +632,375 | +64% | +$2.5M |
|
33
Spyre Therapeutics
SYRE
$996M
| $6.25M | 0.72% | 653,112 +143,994 | +28% | +$1.38M |
|
|
TVRD
34
Tvardi Therapeutics, Inc. Common Stock
TVRD
$281M
| $6.13M | 0.7% | +255,930 | New | +$6.13M |
|
35
Visa
V
$683B
| $6.06M | 0.7% | 40,401 | – | – |
|
|
ARRY
36
DELISTED
Array Biopharma Inc
ARRY
| $6M | 0.69% | 395,000 +55,196 | +16% | +$839K |
|
|
BHVN
37
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $5.84M | 0.67% | 155,515 +18,127 | +13% | +$681K |
|
|
SBBP
38
DELISTED
Strongbridge Biopharma plc.
SBBP
| $5.72M | 0.66% | 1,179,010 +505,014 | +75% | +$2.45M |
|
39
SolarEdge
SEDG
$2.01B
| $5.68M | 0.65% | 150,817 +101,869 | +208% | +$3.84M |
|
40
Q32 Bio
QTTB
$20.9M
| $5.6M | 0.64% | 245,104 +103,268 | +73% | +$2.36M |
|
41
Wabtec
WAB
$33.1B
| $5.57M | 0.64% | 53,114 +6,550 | +14% | +$687K |
|
|
MRTX
42
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $5.32M | 0.61% | 112,908 +98,573 | +688% | +$4.64M |
|
43
International Flavors & Fragrances
IFF
$17.3B
| $5.07M | 0.58% | +36,450 | New | +$5.07M |
|
44
Mastercard
MA
$538B
| $5.07M | 0.58% | 22,760 | – | – |
|
|
PVLA
45
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
| $5.07M | 0.58% | 904,686 +62,054 | +7% | +$347K |
|
46
Larimar Therapeutics
LRMR
$310M
| $5.03M | 0.58% | 430,000 -50,000 | -10% | -$585K |
|
47
Xenon Pharmaceuticals
XENE
$2.98B
| $5.01M | 0.58% | 379,484 -59,550 | -14% | -$786K |
|
|
KDMN
48
DELISTED
Kadmon Holdings, Inc.
KDMN
| $4.98M | 0.57% | 1,490,000 -62,846 | -4% | -$210K |
|
49
Cisco
CSCO
$274B
| $4.87M | 0.56% | 100,000 | – | – |
|
|
BOLD
50
DELISTED
Audentes Therapeutics, Inc
BOLD
| $4.75M | 0.55% | +120,000 | New | +$4.75M |
|